Your browser doesn't support javascript.
loading
The Prevalence of Hepatitis C Virus Antibody in HIV-Negative Persons in Kenya, 2007.
Ly, Kathleen N; Kim, Andrea A; Drobeniuc, Jan; Kodani, Maja; Montgomery, Joel M; Fields, Barry S; Teshale, Eyasu H.
Afiliación
  • Ly KN; Division of Viral Hepatitis, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Kim AA; Division of Global HIV/AIDS, Center for Global Health, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Drobeniuc J; Division of Viral Hepatitis, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Kodani M; Division of Viral Hepatitis, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Montgomery JM; Division of Global Health Protection, Center for Global Health, U.S. Centers for Disease Control and Prevention-Kenya, Atlanta, Georgia.
  • Fields BS; Division of Global Health Protection, Center for Global Health, U.S. Centers for Disease Control and Prevention-Kenya, Atlanta, Georgia.
  • Teshale EH; Division of Viral Hepatitis, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia.
Am J Trop Med Hyg ; 98(6): 1876-1879, 2018 06.
Article en En | MEDLINE | ID: mdl-29692313
ABSTRACT
The prevalence of hepatitis C virus (HCV) infection in the Kenyan population has not been previously determined. We estimated the Kenyan HCV prevalence in HIV-negative persons aged 15-64 years. This is a retrospective cross-sectional study using data from the 2007 Kenya AIDS Indicator Survey-a nationally representative sample of 15,853 persons aged 15-64 years who completed a health interview and provided a blood specimen. Of the 1,091 randomly selected participants, 50 tested positive for HCV antibody using the automated chemiluminescence immunoassay, corresponding to a weighted HCV antibody positivity rate of 4.4% (95% confidence interval 3.3-5.9%) or 848,000 (range 634,000-1,100,000) persons. Hepatitis C virus RNA, a marker for current infection, was not detected in any of the tested antibody-positive specimens. The high HCV antibody prevalence together with no current infection suggests that some HCV antibody serologic testing in Kenya may result in false positives whereas others may be because of spontaneous viral clearance.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Hepatitis C / Hepacivirus / Anticuerpos contra la Hepatitis C Tipo de estudio: Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Adolescent / Adult / Female / Humans / Male / Middle aged País/Región como asunto: Africa Idioma: En Revista: Am J Trop Med Hyg Año: 2018 Tipo del documento: Article País de afiliación: Georgia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Hepatitis C / Hepacivirus / Anticuerpos contra la Hepatitis C Tipo de estudio: Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Adolescent / Adult / Female / Humans / Male / Middle aged País/Región como asunto: Africa Idioma: En Revista: Am J Trop Med Hyg Año: 2018 Tipo del documento: Article País de afiliación: Georgia
...